Wuhan (Novel) Corona Virus -looming pandemy of deadly pneumonia? - Pandemy ongoing!

(December 4, 2020) EuBiologics partners with IVI for COVID-19 vaccine development
The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clinical development
of the COVID-19 vaccine the company is currently developing. The COVID-19 vaccine being developed by EuBiologics
uses two platform technologies: its own immunity enhancement technology (EuIMT) and the antigen display technology
(Spontaneous nanoliposome antigen particleization: SNAP) of the US-based POP Biotech, which EuBiologics has an investment in.
EuBiologics’ own COVID-19 vaccine uses protein subunit (synthetic antigen) technique,
which is the same method as that used by Sanofi and NovaVax, and SK bioscience in Korea.

New WHO estimate puts coronavirus death rate at only 0.13%

https://www.wnd.com/2020/10/4859570/

(December 4, 2020) Pfizer COVID jab warning: No breastfeeding, avoid pregnancy for 2 months, unknown fertility impacts
UK Government produced safety instructions for a new coronavirus vaccine indicate that it should not be used by pregnant or breast-feeding mothers and children.
In addition, they state that it is unknown what effect the COVID-19 mRNA vaccine will have on fertility.
In a section called “Fertility, pregnancy and lactation,” the guide says there is “no or limited data” on the vaccine.
Therefore, it is not recommending its use for pregnant women.
“Animal reproductive toxicity studies have not been completed.
COVID-19 mRNA Vaccine BNT162b2 is not recommended during pregnancy,” the guide states in section 4.6.
But alarmingly the guide has only one thing to say about the vaccine’s impact on fertility: they don’t know if it does or doesn’t.

Abacus wrote:(October 10, 2017) ‘Vaccine investment brings 16-fold return… ; partnering with Bill Gates’
IVI is the world’s only international organization devoted to development and delivery of vaccines for people in developing countries, especially children.
It was established in 1997 as an initiative of the United Nations Development Program (UNDP) and is headquartered in Korea.
“IVI serves as an ‘accelerator’ to develop and deliver vaccines with support from governments, philanthropic foundations and corporate sponsorships,
and coordinates efforts to ensure that vaccines are produced and supplied speedily at affordable prices.”
Director General Kim said the oral cholera vaccine was also developed with support from the Bill & Melinda Gates Foundation (Gates Foundation)
founded by Microsoft co-founder Bill Gates and his wife Melinda Gates, and the Swedish government, among others.
IVI transferred the vaccine technology to a Korean company, EuBiologics, and an Indian firm, which are mass producing the vaccine.
IVI is also developing a vaccine against typhoid fever, a ‘disease of the poor,’ with the aim to have
the vaccine commercialized in three to four years, and pushing to develop a vaccine against MERS through (collaboration with) partner companies.

Thank you I have learn a lot from your updates

khnum wrote:

Abacus wrote:(October 10, 2017) ‘Vaccine investment brings 16-fold return… ; partnering with Bill Gates’
IVI is the world’s only international organization devoted to development and delivery of vaccines for people in developing countries, especially children.
It was established in 1997 as an initiative of the United Nations Development Program (UNDP) and is headquartered in Korea.
“IVI serves as an ‘accelerator’ to develop and deliver vaccines with support from governments, philanthropic foundations and corporate sponsorships,
and coordinates efforts to ensure that vaccines are produced and supplied speedily at affordable prices.”
Director General Kim said the oral cholera vaccine was also developed with support from the Bill & Melinda Gates Foundation (Gates Foundation)
founded by Microsoft co-founder Bill Gates and his wife Melinda Gates, and the Swedish government, among others.
IVI transferred the vaccine technology to a Korean company, EuBiologics, and an Indian firm, which are mass producing the vaccine.
IVI is also developing a vaccine against typhoid fever, a ‘disease of the poor,’ with the aim to have
the vaccine commercialized in three to four years, and pushing to develop a vaccine against MERS through (collaboration with) partner companies.

Thank you I have learn a lot from your updates

khnum wrote:

Abacus wrote:(October 10, 2017) ‘Vaccine investment brings 16-fold return… ; partnering with Bill Gates’
IVI is the world’s only international organization devoted to development and delivery of vaccines for people in developing countries, especially children.
It was established in 1997 as an initiative of the United Nations Development Program (UNDP) and is headquartered in Korea.
“IVI serves as an ‘accelerator’ to develop and deliver vaccines with support from governments, philanthropic foundations and corporate sponsorships,
and coordinates efforts to ensure that vaccines are produced and supplied speedily at affordable prices.”
Director General Kim said the oral cholera vaccine was also developed with support from the Bill & Melinda Gates Foundation (Gates Foundation)
founded by Microsoft co-founder Bill Gates and his wife Melinda Gates, and the Swedish government, among others.
IVI transferred the vaccine technology to a Korean company, EuBiologics, and an Indian firm, which are mass producing the vaccine.
IVI is also developing a vaccine against typhoid fever, a ‘disease of the poor,’ with the aim to have
the vaccine commercialized in three to four years, and pushing to develop a vaccine against MERS through (collaboration with) partner companies.

Thank you I have learn a lot from your updates

You're welcome!

I think we all know that for a long time. It's awesome  how msm suddenly publishes such "breaking news".

An elite Czech doctor in the USA says how to defend covid-19. And take zinc, he advises

https://www.seznamzpravy.cz/clanek/elitni-cesky-lekar-v-usa-rika-cim-se-branit-covidu-19-a-berte-zinek-radi-132451#dop_ab_variant=0&dop_req_id=wTqIQvsYFeO-202012051955&dop_source_zone_name=zpravy.sznhp.box&source=hp&seq_no=2&utm_campaign=&utm_medium=z-boxiku&utm_source=www.seznam.cz

And use D vitamine he says.



What should msm really deal with is why not single one government did anything to support immune system of wide public and, especially, the vulnerable ones. Instead, many governments, during spring and summer season, closed major part of citizens in their homes, amid inhuman, totalitarian lockdowns and only supported vitamine D deficit among public. Especially elders in retirement homes and hospitals are affected by this as they are locked down for almost one year. This is intentional and this is crime against humanity.

The fuckers should be hanged on the lamp posts already.

zerohedge
@zerohedge
·
1m
Secretary Azar Says COVID Vaccine Approval Could Arrive "Within Days"

https://www.zerohedge.com/markets/secretary-azar-says-covid-vaccine-approval-could-arrive-within-days

Elon Musk’s dark plans were exposed by Turkish TV.

Musk wants to implant chips to human beings to turn them into cyborgs pic.twitter.com/UgBx394Tqk

— Ragıp Soylu (@ragipsoylu) December 6, 2020

From today's demonstration. Quite big today. Finally... From 9:00->

This is a WOW clip!

From a renowned scientist, doctor & author on COVID...

His name is Dr. Sucharit Bhakdi

Not only does he call out Dr. Fauci...

He says the COVID-19 vaccine is 'downright dangerous' & will send you 'to your doom' WOW! pic.twitter.com/zKG5xB5gT8

— Spiro (@o_rips) December 4, 2020

https://t.co/4bJg6a5h5P

---FDA List of side effects page 17--- pic.twitter.com/bcZhUhbrCX

— Vincent Black (@VincentBlack69) December 7, 2020

If they think they're going to force me to take that shit, they're in for a serious reality check.

Humanity Blows wrote:If they think they're going to force me to take that shit, they're in for a serious reality check.

They plan to vaccinate about 6 million people over here. I strongly doubt there is so many suicides...

Meanwhile, the flu seems to have taken a long vacation this season:

https://www.cdc.gov/flu/weekly/index.htm

Week 48 (ending 11/28/2020)

No. of specimens tested 17,104
No. of positive specimens (%) 17 (0.1%)
Positive specimens by type
Influenza A 10 (58.8%)
Influenza B 7 (41.2%)

Data Cumulative as of 9/27/2020

No. of specimens tested 195,300
No. of positive specimens (%) 429 (0.2%)
Positive specimens by type
Influenza A 214 (49.9%)
Influenza B 215 (50.1%)

School closures are irrational, not evidence-based, and impose massive harm on students and families. pic.twitter.com/XAjTeRgXe3

— Ron DeSantis (@GovRonDeSantis) December 7, 2020

Imagine my shock. https://t.co/lw8zu2x1T6

— Vincent Black (@VincentBlack69) December 9, 2020

Australia First Minister taken the vaccine, with the cap still in the needle
As I keep saying, all the goverments are following the same script. pic.twitter.com/8fUd5hiP7B

— @Suspicious_Mind (@SUSPICIOUSsMIND) December 8, 2020

(December 4, 2020) Sherlock Biosciences Strengthens Intellectual Property Portfolio in CRISPR-based Diagnostics Through Exclusive License Agreement with Tolo Biotech
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing
better, faster and more affordable, today announced exclusive license agreements with Shanghai-based Tolo Biotech.
Tolo has granted Sherlock exclusive rights in the United States to its CRISPR-Cas12 (including Cas12a and Cas12b) diagnostic technology,
and Sherlock has granted Tolo exclusive rights to the CRISPR-Cas13 SHERLOCK diagnostic platform in Greater China.
Financial details have not been disclosed.
In May 2020, Sherlock received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
for its Sherlock CRISPR SARS-CoV-2 kit, the first FDA-authorized use of CRISPR technology.

(October 22, 2020) Controversial tech firm Palantir is reportedly building a data tool to help US authorities allocate COVID-19 vaccines
Data-analytics firm Palantir, which has drawn fire from human rights groups for its US government contracts,
is reportedly working on a tool to help local authorities decide where to distribute COVID-19 vaccines.
The software Palantir is developing is called Tiberius, and it will pool coronavirus data
to help officials where to allocate vaccines, the Journal reported.
A document created by Palantir about Tiberius, seen by the Journal, said it would
"integrate a wide range of demographic, employment, and public health data
sets to identify the location of priority populations."

(December 7, 2020) Palantir Wins FDA Contract to Power Drug Review, Inspections
The three-year deal is worth $44.4 million and will allow the FDA’s Center for Drug Evaluation
and Research and the Oncology Center of Excellence to use Palantir software to integrate and analyze data.
The FDA contract is one of dozens Palantir has secured with U.S. federal agencies in recent years.
Government work, which Palantir undertakes globally, now makes up more than half of its total revenue.
The company was awarded $21 million in contracts in late April with the U.S. Health and Human Services Department (HHS)
as part of the country’s data collection and analysis platform, HHS Protect.
Since the pandemic began this year, Palantir has secured more than 100 deals with private companies and health and government groups.
More recently, Palantir announced its software (Tiberius) will help power the distribution of Covid-19 vaccines to 300 million Americans through Operation Warp Speed.

(December 8, 2020) HALIX, AstraZeneca Ink Commercial COVID-19 Vax Mfg. Pact
HALIX B.V. signed an agreement with AstraZeneca for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.
HALIX will provide commercial manufacturing of drug substance at its cGMP facility at the Leiden Bio Science Park in the Netherlands.
To meet the increased demand, HALIX has expanded with two additional viral vector production lines.
HALIX continues its key role as one of the original partners in the University of Oxford’s consortium
for the manufacture of AZD1222. The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech.

(December 9, 2020) Health Canada Green Lights COVID-19 Vax
Pfizer Canada and BioNTech SE said that Health Canada has granted Authorization under Interim Order for the emergency use of their mRNA COVID-19 vaccine (BNT162b2).
The distribution of the vaccine in Canada will be prioritized according to the populations identified in guidance from the National Advisory Committee on Immunizations (NACI).
BioNTech will hold the regulatory approval in Canada, while Pfizer Canada will have the commercialization rights.
Pfizer will have the marketing and distribution rights worldwide with the exception of China, Germany and Turkey.

(December 9, 2020) PostEra, Pfizer ink pact to advance machine learning for drug discovery
PostEra, a biotechnology company, announced a strategic partnership with Pfizer
with the goal of accelerating small molecule drug discovery
by developing a platform technology based on generative chemistry.
PostEra's machine learning technology is intended to accelerate the drug discovery process
by designing novel molecular structures with optimised potency and drug-like properties.
PostEra will receive an upfront payment and is eligible to receive additional payments as the project progresses.
PostEra will also retain ownership rights to all algorithms developed during the collaboration.

(December 9, 2020) Fareva enhancer: CureVac to use CDMO for COVID vaccine fill/finish
Under terms of the deal – financials of which have not been disclosed – contract development and manufacturing organization (CDMO) Fareva
will provide fill and finish capabilities for CureVac’s COVID-19 vaccine candidate, CVnCoV, from facilities in Val-de-Reuil and Pau, both in France.
Fareva has invested over €80 million ($97 million) in its Val-de-Reuil facility over the past decade,
but Pau is a brand new extension for the CDMO, having just acquired the plant – along with a monoclonal antibody production plant
in Saint-Julien-en-Genevois, France – from French drugmaker Pierre Fabre.

NJ Lawmaker Wants Mandatory COVID Shot For All Kids Without Exemption https://t.co/mnWJS0MlHa

— zerohedge (@zerohedge) December 11, 2020

Oh ffs...

Australia Scraps Billion Dollar Coronavirus Vaccine After Participants Test HIV Positive

‘Overall it just didn’t look like it was going to be a successful vaccine, that’s why we were surprised when the government committed millions of dollars to it, it just seemed disproportionate.’ https://t.co/LrCWcmPR5N

— Cynthia McKinney PhD (@cynthiamckinney) December 11, 2020

(December 9, 2020) Malaysia joins CEPI donating $3 M to advance vaccine R&D
Malaysia has announced funding of $3 million to the Coalition for Epidemic Preparedness Innovations (CEPI)
to help support CEPI’s work to advance the development of vaccines against emerging epidemic threats.
Malaysia also last week joined COVAX, a global initiative co-led by CEPI, Gavi, the Vaccine Alliance, and the World Health Organization (WHO),
working to ensure the globally fair allocation of 2 billion doses of COVID-19 vaccines by the end of 2021 to end the acute phase of the pandemic.
With the UK and Norway working as COVAX partners and established coalition members within CEPI, H.E. Mr. Charles Hay, High Commissioner of the British High Commission,
and H.E. Ms. Gunn Jorid Roset, Ambassador of Royal Norwegian Embassy in Malaysia,
were also in attendance at the virtual signing ceremony to discuss the new partnership.

(December 10, 2020) SK Bioscience chosen to receive $10mn from CEPI for vaccine development
SK Bioscience’s second Covid-19 vaccine candidate GBP510 has been chose to receive $10 million
in funding from the Coalition for Epidemic Preparedness Innovations (CEPI),
becoming the first to be supported as part of the global partnership’s Wave 2 initiative,
the South Korean company said on Wednesday. CEPI is a global health partnership launched in 2017
with the aim to accelerate the development of vaccines against infectious diseases and enable
equitable access to these vaccines during outbreaks. Last month, the organization launched the Wave 2 project
with donations from the Bill & Melinda Gates Foundation to fund effective Covid-19 vaccine development.
GBP510, once developed, will be supplied to the world to more than 180 countries
and economies through the Covax Facility led by CEPI, Gavi, the Vaccine Alliance, and the World Health Organization (WHO).
GBP510 is a coronavirus vaccine candidate that SK Biosciences started development in collaboration with the Institute for Protein Design at the University of Washington
in Seattle in May with a grant from BMGF.

(December 11, 2020) 64 foreign ambassadors visit Hyderabad to take stock of COVID-19 vaccine manufacturing process at Bharat Biotech
The ambassadors of all the 64 countries were taken on a tour of Bharat Biotech and Biological E vaccine manufacturing companies located in Hyderabad.
“The visit of HoMs of various countries to the leading vaccine manufacturing companies is first of its kind trip taken up in the country.
The main objective is to give a firsthand experience of the vaccine manufacturing facilities
and the processes being taken up by leading firms in India to the world countries.
Apart from Hyderabad, the central government is also planning similar trip for the HoMs (heads of missions)
to other vaccine manufacturing facilities located in other cities across the country,” informed the Chief Secretary.